One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Highlights of the current issue
doi : 10.1016/j.dsx.2025.103354
Volume 19, Issue 11, November 2025, 103354
Burden and trends of diabetic kidney disease in East Asia, 1990–2038: An analysis of the global burden of disease study 2023
Low dose pioglitazone (7.5 mg) provides efficacious glycemic control in Asian Indian patients with poorly controlled diabetes compared to 15 mg: A pilot randomized controlled parallel-group open-label trial over 12 months☆
Impact of sodium-glucose co-transporter-2 inhibitor combined with mineralocorticoid receptor antagonist therapy versus either agent alone in individuals with chronic kidney disease: A systematic review and meta-analysis
Gliclazide in type 2 diabetes: Cost-effective and clinically relevant in resource-limited settings
